A 2.6 Mb deletion of 6q24.3-25.1 in a patient with growth failure, cardiac septal defect, thin upper lip and asymmetric dysmorphic ears

被引:15
作者
Caselli, R.
Mencarelli, M. A.
Papa, F. T.
Uliana, V.
Schiavone, S.
Strambi, M.
Pescucci, C.
Ariani, F.
Rossi, V.
Longo, I.
Meloni, I.
Renieri, A.
Mari, F.
机构
[1] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy
[2] Univ Padua, Dept Biol, Padua, Italy
关键词
chromosome; 6; array CGH; 6q interstitial deletion; ears abnormalities; cardiac septal defect; PPP1R14C;
D O I
10.1016/j.ejmg.2007.03.003
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We report a female patient with neurodevelopmental delay and peculiar facial features. She has postnatal growth failure and an atrial septal defect. Patent duct arteriosis and tricuspidal insufficiency were also noted at birth. Characteristic facial features include medial flare eyebrows, dysmorphic helix of the right car, cupshaped left ear, anteverted nares, long and smooth philtrum, thin upper lip, high vaulted palate. Array-CGH analysis demonstrated the presence of a 2.6 Mb deletion in 6q24.3-25.1. The phenotypic features of this case are very similar to those previously reported in a patient with a 7 Mb overlapping deletion, pointing to a specific new syndrome. Twenty-two genes are present in the common critical deleted region. Among them,there is the PPPIR14C gene that encodes for KEPI, a PKC-potentiated inhibitory protein for type-1 Ser/Thr protein phosphatase. Its selective distribution in brain and heart well correlates with developmental delay and cardiac anomalies observed in the patient. (c) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 15 条
[1]   Additional chromosomal abnormalities in patients with a previously detected abnormal karyotype, mental retardation, and dysmorphic features [J].
Bisgaard, Anne-Marie ;
Kirchhoff, Maria ;
Tumer, Zeynep ;
Jepsen, Birgit ;
Brondum-Nielsen, Karen ;
Cohen, Monika ;
Hamborg-Petersen, Bente ;
Bryndorf, Thue ;
Tommerup, Niels ;
Skovby, Flemming .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (20) :2180-2187
[2]   DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission [J].
Fienberg, AA ;
Hiroi, N ;
Mermelstein, PG ;
Song, WJ ;
Snyder, GL ;
Nishi, A ;
Cheramy, A ;
O'Callaghan, JP ;
Miller, DB ;
Cole, DG ;
Corbett, R ;
Haile, CN ;
Cooper, DC ;
Onn, SP ;
Grace, AA ;
Ouimet, CC ;
White, FJ ;
Hyman, SE ;
Surmeier, DJ ;
Girault, JA ;
Nestler, EJ ;
Greengard, P .
SCIENCE, 1998, 281 (5378) :838-+
[3]  
FRYNS JP, 1991, ANN GENET-PARIS, V34, P127
[4]   Mouse brain localization of the protein kinase C-enhanced phosphatase 1 inhibitor kepi (kinase C-enhanced PP1 inhibitor) [J].
Gong, JP ;
Liu, QR ;
Zhang, PW ;
Wang, Y ;
Uhl, GR .
NEUROSCIENCE, 2005, 132 (03) :713-727
[5]   Beyond the dopamine receptor: the DARPP-32/Protein phosphatase-1 cascade [J].
Greengard, P ;
Allen, PB ;
Nairn, AC .
NEURON, 1999, 23 (03) :435-447
[6]   Expression of protein phosphatases during postnatal development of rabbit heart [J].
Kumar, R ;
Joyner, RW .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 245 (1-2) :91-98
[7]   KEPI, a PKC-dependent protein phosphatase I inhibitor regulated by morphine. [J].
Liu, QR ;
Zhang, PW ;
Zhen, QX ;
Walther, D ;
Wang, XB ;
Uhl, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) :13312-13320
[8]  
Livak K., 1997, ABI PRISM 7700 SEQUE
[9]   CHROMOSOME-6Q DELETIONS - A REPORT OF 2 ADDITIONAL CASES AND A REVIEW OF THE LITERATURE [J].
MCLEOD, DR ;
FOWLOW, SB ;
ROBERTSON, A ;
SAMCOE, D ;
BURGESS, I ;
HOO, JJ .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1990, 35 (01) :79-84
[10]   2 PATIENTS WITH CHROMOSOME-6Q TERMINAL DELETIONS WITH BREAKPOINTS AT Q24.3 AND Q25.3 [J].
MENG, JG ;
FUJITA, H ;
NAGAHARA, N ;
KASHIWAI, A ;
YOSHIOKA, Y ;
FUNATO, M .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 43 (04) :747-750